NeuroMetrix - Stock Price History | NURO

Historical daily share price chart and data for NeuroMetrix since 2020 adjusted for splits. The latest closing stock price for NeuroMetrix as of February 18, 2020 is 2.93.
  • The all-time high NeuroMetrix stock closing price was 46510.67 on May 09, 2006.
  • The NeuroMetrix 52-week high stock price is 6.15, which is 109.9% above the current share price.
  • The NeuroMetrix 52-week low stock price is 0.25, which is 91.5% below the current share price.
  • The average NeuroMetrix stock price for the last 52 weeks is 1.40.
NeuroMetrix Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.0789 0.8300 5.1900 0.2655 4.3000 465.79%
2018 1.3121 1.7500 2.0800 0.6785 0.7600 -56.04%
2017 3.2733 5.7640 6.7664 1.5100 1.7290 -70.74%
2016 12.2632 14.8800 16.6080 5.1600 5.9088 -62.70%
2015 35.5508 61.4400 61.4400 15.8400 15.8400 -74.62%
2014 64.0445 93.4400 93.4400 50.2432 62.4000 -33.22%
2013 69.1510 88.3023 100.1600 48.0000 93.4400 12.55%
2012 137.9607 253.3893 282.1836 83.0234 83.0234 -65.40%
2011 487.6891 692.1903 724.3182 239.9520 239.9520 -69.35%
2010 1408.8229 2848.9083 2848.9083 581.4122 782.9316 -72.47%
2009 2311.0293 898.2007 3938.2645 783.0467 2844.3022 183.91%
2008 2855.7579 11031.7469 12632.3865 598.8005 1001.8392 -90.54%
2007 10794.7867 16697.3204 16697.3204 8348.6602 10594.1619 -38.30%
2006 32036.3061 32243.1015 46510.6739 15568.8119 17169.4515 -45.34%
2005 23785.5660 12977.8483 42871.8096 10421.4310 31413.9931 132.17%
2004 10486.4324 9269.8917 13530.5872 8509.8757 13530.5872 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.004B $0.009B
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $158.560B 27.67
Medtronic (MDT) Ireland $157.266B 21.73
Stryker (SYK) United States $82.983B 26.82
Boston Scientific (BSX) United States $58.973B 26.61
Baxter (BAX) United States $47.553B 28.84
EssilorLuxottica Societe Anonyme (ESLOY) France $33.044B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.992B 20.38
Lonza Group Ag (LZAGY) Switzerland $31.551B 0.00
Coloplast (CLPBY) Denmark $29.743B 45.90
Terumo (TRUMY) Japan $27.160B 33.90
ResMed (RMD) United States $25.539B 44.37
Smith & Nephew SNATS (SNN) United Kingdom $20.941B 0.00
Sunny Optical Technology (SNPTF) China $18.537B 0.00
Insulet (PODD) United States $13.126B 624.47
Bio-Rad Laboratories (BIO) United States $12.082B 56.45
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Perrigo (PRGO) Ireland $7.855B 14.65
Canopy Growth (CGC) Canada $7.731B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Hill-Rom Holdings (HRC) United States $7.334B 21.09
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.077B 37.41
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.648B 0.00
ICU Medical (ICUI) United States $4.424B 28.84
NuVasive (NUVA) United States $4.127B 32.50
GW Pharmaceuticals (GWPH) United Kingdom $3.926B 0.00
Neogen (NEOG) United States $3.835B 63.83
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.773B 0.00
Quidel (QDEL) United States $3.367B 29.56
Agios Pharmaceuticals (AGIO) United States $3.033B 0.00
National Vision Holdings (EYE) United States $2.670B 60.27
Aurora Cannabis (ACB) Canada $1.847B 0.00
AtriCure (ATRC) United States $1.734B 0.00
TG Therapeutics (TGTX) United States $1.571B 0.00
Cardiovascular Systems (CSII) United States $1.560B 0.00
InMode (INMD) Israel $1.406B 0.00
NanoString Technologies (NSTG) United States $1.204B 0.00
Aphria (APHA) $1.151B 0.00
Phibro Animal Health (PAHC) United States $1.095B 21.65
VAREX IMAGING (VREX) United States $0.997B 20.71
PetIQ (PETQ) United States $0.956B 23.32
Quanterix (QTRX) United States $0.790B 0.00
Cerus (CERS) United States $0.779B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.721B 27.60
Lantheus Holdings (LNTH) United States $0.653B 16.31
Omeros (OMER) United States $0.653B 0.00
LeMaitre Vascular (LMAT) United States $0.602B 34.22
Surmodics (SRDX) United States $0.535B 61.52
MacroGenics (MGNX) United States $0.497B 0.00
Organigram Holdings (OGI) Canada $0.444B 0.00
HEXO (HEXO) $0.432B 0.00
OraSure Technologies (OSUR) United States $0.422B 25.33
Owens & Minor (OMI) United States $0.420B 15.56
Utah Medical Products (UTMD) United States $0.348B 24.71
Meridian Bioscience (VIVO) United States $0.338B 13.62
Zynex (ZYXI) United States $0.333B 37.63
BioLife Solutions (BLFS) United States $0.313B 127.42
Female Health (VERU) United States $0.275B 0.00
Bovie Medical (APYX) United States $0.268B 0.00
Repro-Med Systems (KRMD) United States $0.238B 0.00
Vapotherm (VAPO) United States $0.219B 0.00
Viemed Healthcare (VMD) United States $0.213B 22.48
United Health Products (UEEC) United States $0.188B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Cytosorbents (CTSO) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.136B 0.00
Fonar (FONR) United States $0.131B 9.52
Chimerix (CMRX) United States $0.103B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
MRI Interventions (CLPT) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
United-Guardian (UG) United States $0.079B 20.02
MTech Acquisition (KERN) United States $0.078B 0.00
Nephros (NEPH) United States $0.071B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) Canada $0.044B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Valeritas Holdings (VLRX) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00